Do erythropoietin receptors on cancer cells explain unexpected clinical findings? [5]

Journal of Clinical Oncology

Volumn 25, Issue 11, 2007, Pages 1447-1448

  Clavo, Bernardino ^a  

^a Madrid Spain

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; HEMOGLOBIN;

ANEMIA; BLOOD FLOW; CANCER CELL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; HEMATOCRIT; HUMAN; LETTER; MEDICAL LITERATURE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION DOSE; VASCULAR RESISTANCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE PROGRESSION; ERYTHROPOIETIN, RECOMBINANT; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, ERYTHROPOIETIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34248195397     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.9713     Document Type: Letter

References (20)

1. Henke M, Mattern D, Pepe M, et al: Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol 24:4708-4713, 2006
2. Henke M, Laszig R, Rube C, et al: Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-controlled trial. Lancet 362:1255-1260, 2003
3. Kaanders, JH, van der Kogel AJ: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:78-79, 2004
4. Haddad R, Posner M: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:79-80, 2004
5. Leyland-Jones B, Mahmud S: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:81-82, 2004
6. Blumberg N, Heal JM: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:81-82, 2004
7. Freidlin B, Korn EL: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:81-82, 2004
8. Powles T, Shamash J, Liu W: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:82, 2004
9. Vaupel P, Mayer A: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:992, 2004
10. Gemici C: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:992-993, 2004
11. Janecka IP: Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363:993-994, 2004
12. Biete Sola A, Calvo Manuel FA, Clavo Varas B, et al: Erythropoietin in cancer treatment: Considerations about Henke's article. Clin Transl Oncol 7:332-335, 2005 Lancet 363:81-82, 2004
13. Fyles AW, Milosevic M, Pintilie M, et al: Anemia, hypoxia and transfusion in patients with cervix cancer: A review. Radiother Oncol 57:13-19, 2000
14. Joiner B, Hirst VK, McKeown SR, et al: The effect of recombinant human erythropoietin treatment on tumour radiosensitivity and cancer-associated anaemia in the mouse. Br J Cancer 68:720-726, 1993
15. Thews O, Koenig R, Kelleher DK, et al: Enhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemia. Br J Cancer 78:752-756, 1998
16. Kelleher DK, Thews O, Vaupel P: Modulation of tumor oxygenation and radiosensitivity by erythropoietin, in Vaupel P, Kelleher DK (eds): Tumor Hypoxia. Stuttgart, Wissenschaftliche Verlagsgesellschaft, 1999, pp 83-90
17. Stuben G, Thews O, Pottgen C, et al: Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice. J Cancer Res Clin Oncol 127:346-350, 2001
18. Vaupel P, Thews O, Mayer A, et al: Oxygenation status of gynecologic tumors: What is the optimal hemoglobin level? Strahlenther Onkol 178:727-731, 2002
19. Rizzo JD, Lichtin AE, Woolf SH, et al: Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 20:4082-4107, 2002
20. Batra S, Perelman N, Luck LR, et al: Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83:1477-1487, 2003